The HDL dysfunction gains momentum : is it time for a new approach in rheumatic diseases?
| Errataetall: |
CommentOn: Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. - PMID 32830270 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Rheumatology (Oxford, England) - 59(2020), 11 vom: 01. Nov., Seite 3121-3123 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rodríguez-Carrio, Javier [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.01.2021 Date Revised 13.01.2021 published: Print CommentOn: Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. - PMID 32830270 Citation Status MEDLINE |
|---|
| doi: |
10.1093/rheumatology/keaa346 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM314039031 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM314039031 | ||
| 003 | DE-627 | ||
| 005 | 20231225151854.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/rheumatology/keaa346 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1046.xml |
| 035 | |a (DE-627)NLM314039031 | ||
| 035 | |a (NLM)32830277 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rodríguez-Carrio, Javier |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The HDL dysfunction gains momentum |b is it time for a new approach in rheumatic diseases? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.01.2021 | ||
| 500 | |a Date Revised 13.01.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Rheumatology (Oxford). 2020 Nov 1;59(11):3515-3525. - PMID 32830270 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Lipoproteins, HDL |2 NLM | |
| 700 | 1 | |a Suárez, Ana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology (Oxford, England) |d 1999 |g 59(2020), 11 vom: 01. Nov., Seite 3121-3123 |w (DE-627)NLM102581908 |x 1462-0332 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2020 |g number:11 |g day:01 |g month:11 |g pages:3121-3123 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/rheumatology/keaa346 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2020 |e 11 |b 01 |c 11 |h 3121-3123 | ||